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ABSTRACT: Obesity has been associated with higher risk of frailty in older adults, but the pathophysiological 
mechanisms are unclear. No previous study has examined the association between leptin, an adipokine, and the 
risk of frailty in older adults, and whether this association could be explained by insulin resistance or chronic 
inflammation. Data were taken from 1,573 individuals without diabetes mellitus, aged ≥60 years, from the 
Seniors-ENRICA cohort. In 2008-2010, leptin, the homeostasis model assessment of insulin resistance (HOMA-
IR) and C-reactive protein (CRP) were measured. Study participants were followed-up through 2012 to assess 
incident frailty, defined as at least two of the following Fried criteria: exhaustion, weakness, low physical 
activity, and slow walking speed. Analyses were performed with logistic regression and adjusted for the main 
confounders. Over a median follow-up of 3.5 years, 280 cases of incident frailty were identified. Compared to 
individuals in the lowest tertile of serum leptin, those in the highest tertile showed an increased risk of frailty 
(odds ratio [OR]: 2.12; 95% confidence interval [CI]: 1.47-3.06; p-trend <0.001). Further adjustment for the 
percentage of body fat led to an OR of 1.69 (95% CI: 1.11-2.61; p-trend=0.01). After additional adjustment for 
HOMA-IR and CRP, the OR for frailty was 1.59 (95% CI: 1.01-2.52; p-trend=0.04). Results did not vary 
according to sex, abdominal obesity or the percentage of body fat. Being in the highest versus lowest tertile of 
leptin was associated with increased risk of exhaustion (OR: 2.16; 95% CI: 1.32-3.55; p-trend=0.001) and 
muscle weakness (OR: 1.77; 95% CI: 1.25-2.51; p-trend=0.001), in the analyses adjusted for potential 
confounders and body fat. Higher leptin concentration was associated with greater risk of frailty in older adults. 
This association was only modestly explained by insulin resistance and chronic inflammation, as measured by 
CRP. 
 
Key words: older adults, leptin, biological markers; obesity, insulin resistance 
 
 
Frailty is a common geriatric medical syndrome whose 
frequency is expected to increase over the next decades 
due to the progressive ageing of the population. The 
frailty syndrome is characterized by an augmented risk of 
falls, hospitalization, disability and death after exposure 
to even minor stressors, such as a mild infection or a new 
drug treatment (1-2). Frailty results from a decline in 
multiple physiological systems, including the endocrine 
system. Specifically, general and abdominal obesity are 
known risk factors for frailty (3-6). Also, obesity-related 
     Volume 8, Number 2; 240-249, April 2017                       
 Lana A., et al                                                                                                                    Leptin and frailty in older adults 
Aging and Disease • Volume 8, Number 2, April 2017                                                                               241 
 
biomarkers of altered glucose metabolism and chronic 
inflammation have been linked to frailty. For instance, 
higher insulin resistance (IR) and C-reactive protein 
(CRP) have been prospectively associated with greater 
risk of frailty among adults aged 69 to 74 years 
participating in the Cardiovascular Heart Study (CHS) 
(7).  
Adipokines (proteins secreted by the adipose tissue) 
are considered to be a link, at least partially, between 
obesity and its related morbidity and mortality (8). Leptin, 
the first adipokine discovered, is secreted mainly by white 
adipocyte tissue, and its serum levels are positively 
correlated with fat mass; therefore, serum leptin reflects 
primarily the amount of energy stored in adipose tissue 
(9,10). It is known that leptin contributes to the regulation 
of energy balance by acting on multiple central (brain) and 
peripheral tissues, but its role in health and disease is still 
incompletely understood. Among healthy individuals, 
higher serum leptin leads to increased satiation and 
reduced food intake as well as higher energy expenditure 
(9,10). However, serum leptin is usually elevated in obese 
individuals, which suggests that there might be a state of 
leptin resistance, whereby leptin is not able to control 
obesity by appropriately reducing food consumption (11). 
Also there is some evidence that leptin upregulates 
proinflammatory cytokines such as tumor necrosis factor-
alpha and interleukin-6, and that these are associated with 
IR (9,10). However, to our knowledge, no previous study 
has investigated the association between leptin and frailty, 
together with the role of IR and chronic inflammation.   
Accordingly, in a cohort of community-dwelling 
older adults we examined the association between serum 
leptin concentrations and the risk of frailty, and whether 
it could be explained by IR and chronic inflammation. 
Moreover, we assessed whether the study association was 
modified   by fat mass.   
MATERIALS AND METHODS 
Study design and participants 
We used data from the Seniors-ENRICA cohort, whose 
methods have been reported elsewhere (6,12). Briefly, 
this population-based cohort was established in 2008-
2010 with 2,614 individuals aged ≥60 years in Spain. 
Baseline information was collected using two procedures. 
The first was a phone interview on health status, lifestyle, 
morbidity, and health services use. This interview was 
followed by two consecutive home visits to collect 12-h 
fasting blood and urine samples, perform a physical exam, 
and obtain a diet history. In 2012, a second wave of data 
collection was performed using the same procedures for 
data collection. During follow-up, 95 individuals died and 
115 were lost, so information was obtained for only 2,404 
persons in 2012. The socio-demographic, lifestyle and 
clinical characteristics at baseline were similar in those 
who provided updated information on frailty at 2012 and 
those who did not (13).  
The Clinical Research Ethics Committee of the ‘La 
Paz’ University Hospital approved the study protocol. All 
study participants gave written informed consent. 
Study variables 
Frailty 
We used a modification of the operational definition 
proposed by Fried et al. in the CHS (1). Specifically, 
frailty was defined as having at least two of the following 
four criteria: a) exhaustion, based on reporting “at least 3 
to 4 days a week” for any of two statements from the 
Depression Scale of the Center for Epidemiological 
Studies: “I felt that anything I did was a big effort” or “I 
felt that I could not keep on doing things”; b) weakness, 
defined as the lowest quintile in the CHS of maximum 
strength on the dominant hand adjusted for sex and body 
mass index. We selected the highest value of grip strength 
in two consecutive measures using a Jamar hand held 
dynamometer; c) low physical activity, defined as 
walking ≤2.5 h/week in men and ≤2 h/week in women; 
and d) slow walking speed, defined as the highest quintile 
in our study sample for the three-meter walking speed test, 
stratified for sex and BMI. As in previous studies on the 
association between diet and risk of frailty (14,15), in the 
main analyses we excluded the “weight loss” criterion 
from the definition of frailty because overfeeding is a 
main cause of both leptin elevation and weight gain (9), 
and thus may confound a potential association between 
leptin and weight loss. However, in sensitivity analyses 
we also included the “weight loss” criterion, so that frailty 
was defined as the presence of at least three of the five 
Fried criteria, including a weight loss ≥4.5 kg in the 
preceding year.   
Leptin and other biomarkers 
Baseline serum leptin concentration (ng/mL) was 
determined by enzyme-linked immunoassay (Diagnosis 
Biochem Canada) using a BEST2000 robot. The 
sensitivity of this test was 0.5 ng/dL and the coefficients 
of variation intra- and inter-assay were 7.5 and 9.6%, 
respectively. Fasting glucose (mg/dL) was measured by 
the glucose oxidase method, and fasting insulin (µU/mL) 
by immunoradiometric assay. The homeostatic model 
assessment for IR index (HOMA-IR) was calculated by 
multiplying fasting glucose by fasting insulin and 
dividing by 405 (16). Finally, high-sensitivity CRP 
(mg/L) was determined by latex-enhanced nephelometry. 
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The coefficients of variation intra- and inter-assay were 
<4% and <4% for glucose, 5.2 and 6.9% for insulin and 
3.2 and 5.9% for CRP. 
Other variables 
We also collected baseline data on some potential 
confounders of the association between leptin and frailty. 
Specifically, we asked study participants about socio-
demographic factors and lifestyle behaviors, such as sex, 
age, education, tobacco and alcohol consumption, leisure-
time physical activity (17), and time spent watching TV. 
Food consumption was ascertained with a validated diet 
history, developed from that used in the EPIC-cohort in 
Spain (18). From this, we calculated the total energy 
intake and the Trichopoulou index (19); a higher score in 
this index indicates better adherence to the Mediterranean 
diet. We also collected health status variables. First, waist 
circumference, weight and height were measured by 
trained staff under standardized conditions (12). 
Abdominal obesity was defined as waist circumference 
>102 cm in men and >88 cm in women. Body mass index 
(BMI) was calculated as weight in kg divided by squared 
height in m. The CUN-BAE equation was used to estimate 
the percentage (%) of body fat, based on sex, age and BMI 
in each study participant (20). Second, participants also 
reported if they suffered from any of the following 
physician-diagnosed diseases: cardiovascular disease 
(myocardial infarction, stroke or heart failure), 
hypertension, cancer at any site, chronic lung disease 
(asthma or chronic bronchitis), osteomuscular disease 
(osteo-arthritis, arthritis, hip fracture), or depression 
requiring drug treatment. Third, the Lawton-Brody index 
was used to ascertain limitations in instrumental activities 
of daily living (IADL), with the questions on subjects’ 
ability to prepare meals, do household chores, and take 
care of personal laundry being excluded in men (21). And 
fourth, individuals reported their self-rated health, which 
was classified as optimal (excellent, very good, or good) 
or suboptimal (fair or poor).   
Statistical analysis 
Among the 2,404 study participants, we excluded 5 
subjects with BMI <18.5 kg/m2 and 374 with diabetes 
mellitus (fasting serum glucose >126 mg/dL or treatment 
with oral anti-diabetic drugs or insulin), because cachexia, 
diabetes or its treatment are strongly associated both with 
leptin and frailty status (22,23). We additionally excluded 
419 who were frail at baseline or lacked data on frailty at 
baseline or at the end of follow-up. Finally, we excluded 
25 individuals without blood determinations and 8 with 
missing data on potential confounders. Therefore, the 
analyses were conducted with 1,573 nondiabetic 
individuals.  
The association between leptin concentration and 
the risk of frailty was estimated by odds ratios (OR) and 
their 95% confidence interval (CI), obtained from logistic 
regressions. Given that serum leptin did not follow a 
normal distribution, we used the log-transformed values. 
Then, participants were classified into sex-specific 
tertiles, because leptin levels were much higher in women 
than men; the lowest tertile of leptin was used as reference 
in the analyses. We built four logistic models. The first 
one adjusted only for age (years) and sex. The second 
model additionally adjusted for educational level 
(primary, secondary or university), smoking (never, 
former or current), alcohol consumption (never, former, 
moderate, or heavy drinker, with the threshold between 
moderate and heavy drinking established as 20 g/d in men 
and 10 g/d in women the threshold between moderate and 
heavy drinking), leisure physical activity (quartiles of 
METs-h/week), energy intake (quartiles of kcal/day), 
Mediterranean diet score, hypertension, cardiovascular 
disease, cancer, chronic obstructive lung disease, 
osteomuscular disease, and depression. A third model was 
additionally adjusted for percentage of body fat (sex-
specific quartiles), as a proxy for the concentration of 
adipokines other than leptin. Finally, a fourth model 
further adjusted for HOMA-IR and CRP (mg/dl), to assess 
if they could explain the association between leptin and 
frailty. To investigate the linear dose-response 
relationship, we modeled leptin tertiles as a continuous 
variable, and the p for linear trend was estimated.  
Several sensitivity analyses were run to assess the 
robustness of results. First, we repeated the analyses using 
the weight loss criterion of frailty, so that this syndrome 
was defined as having three or more of the five Fried 
criteria. Second, we replicated the analyses using the 
lowest quintile of grip strength in our sample to define 
weakness. Thus, in this sensitivity analysis, frailty was 
defined using our own cut-off points for all criteria. Third, 
given the strong association between frailty, disability and 
poor health, analyses were also repeated among 
individuals with better health status (no limitations in 
IADL, optimal self-rated health or without diagnosed 
chronic disease). Lastly, to rule out the possibility that 
sedentary behavior and poor diet lead to both higher leptin 
level and frailty, the analyses were replicated among those 
who watched less TV than the sample median (2 h/day) or 
had a Trichopoulou index higher than the sample median 
(5 points).   
Because the physiology of leptin in the non-obese 
status may differ from that in obesity, where a resistance 
to the effect of leptin has been suggested, we conducted 
analyses stratified by abdominal obesity and the sex-
specific median of body fat percentage. To assess if the 
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study association varied across the strata we built 
interaction terms as the product of leptin tertiles by the 
stratification variable, and then used likelihood ratio tests 
to compare models with and without interaction terms. 
Lastly, we used the same type of analyses to assess the 
association between leptin level and each frailty criterion.   
We tested if the main results varied with sex by using 
interaction terms. Since the results were similar in each 
sex and the interactions did not reach statistical 
significance, the results are reported for the total study 
sample. A 2-tailed p value <0.05 was considered as 
statistically significant. Statistical analyses were 
performed with Stata, version 12.0 (Stata Corp., College 
Station).  
 
 
Table 1. Characteristics of study participants according to sex-specific tertilesa of serum leptin 
concentration. (N=1,573) 
 
 Leptin concentration  
 
Tertile 1 
(lowest) 
Tertile 2 
Tertile 3 
(highest) 
p-trend 
Participants, n  528 531 514  
Age, y 68.4 (6.6) 68.0 (6.0) 68.9 (6.3) 0.17 
Men, % 46.6 46.3 46.9 0.93 
University education, % 25.2 21.1 19.5 0.03 
Current smoker, % 13.1 12.1 9.0 0.04 
Moderate drinker, % 56.3 59.7 59.1 0.34 
Leisure-time physical activity, MET-
h/wk 
24.2 (15.8) 22.6 (14.9) 19.3 (14.3) <0.001 
TV watching, h/d 2.2 (1.3) 2.5 (1.4) 2.8 (1.7) <0.001 
Energy, kcal/d 2,040 (556) 2,051 (561) 2,014 (567) 0.46 
Trichopoulou index score 4.7 (1.5) 4.5 (1.5) 4.4 (1.6) 0.02 
Waist circumference, cm 89.2 (10.5) 95.8 (9.1) 104.2 (10.6) <0.001 
Body fat, % 33.9 (6.5) 36.8 (6.5) 40.5 (7.2) <0.001 
Morbidity, %     
 Cardiovascular disease 4.4 4.9 4.5 0.92 
 Hypertension 54.0 60.6 73.0 <0.001 
 Chronic lung disease 4.7 7.9 9.5 0.003 
 Cancer 1.5 2.3 1.8 0.77 
 Osteomuscular disease 40.7 49.2 52.3 <0.001 
 Depression 6.4 7.0 9.5 0.06 
Independent in IADL, % 91.3 90.2 88.3 0.02 
Optimal self-rated health, % 78.8 71.0 62.8 <0.001 
HOMA-IR 1.4 (1.0) 2.0 (1.1) 3.0 (2.0) <0.001 
CRP, mg/L 0.25 (0.4) 0.39 (0.9) 0.43 (0.7) <0.001 
 
For continuous variables mean and standard deviation (SD) are reported. 
MET-Metabolic equivalent; TV: Television; IADL: Instrumental activities of daily living; HOMA-IR: Homeostasis model 
assessment of insulin resistance; CRP: C-reactive protein. 
aSex-specific tertile cut-points for leptin were 6.5 and 13.6 ng/mL in men and 22.5 and 37.0 ng/mL in women 
 
RESULTS  
Among the study participants, the mean (±standard 
deviation) serum leptin concentration was 23.3 (±19.8) 
ng/mL, and it was significantly higher in women 
(33.1±21.2) than in men (12.1±9.7). Table 1 shows the 
socio-demographic, behavioral and health status 
characteristics of the participants according to the sex-
specific leptin tertiles. Compared to those in the lowest 
tertile, those with higher leptin concentrations had lower 
education, were less frequently current smokers, 
performed less recreational physical activity, spent longer 
time watching TV, and presented lower adherence to the 
Mediterranean diet, with higher waist circumference and 
higher body fat percentage. Moreover, they showed a 
higher frequency of hypertension, chronic lung disease or 
osteomuscular diseases as well as lower frequency of 
IADL-independence and optimal self-rated health. 
Finally, higher leptin levels were positively associated 
with HOMA-IR and CRP concentration.  
 
 Lana A., et al                                                                                                                    Leptin and frailty in older adults 
Aging and Disease • Volume 8, Number 2, April 2017                                                                               244 
 
Table 2. Odds ratios (95% confidence interval) for the association between serum concentration of leptin and risk of 
frailty, in the total study sample and according to characteristics of study participants. (N=1,573) 
 
   Leptin concentration  
                 
Tertile 1 
(lowest) 
Tertile 2 
Tertile 3 
(highest) 
p-trend 
Overall      
 Participants, n 528 531 514  
 Frailty cases 65 82 133  
 Model 1a 1.00 1.38 (0.96-1.99) 2.57 (1.83-3.60) <0.001 
 Model 2b 1.00 1.27 (0.87-1.87) 2.12 (1.47-3.06) <0.001 
 Model 3c 1.00 1.19 (0.79-1.78) 1.69 (1.11-2.61) 0.01 
 Model 4d 1.00 1.14 (0.75-1.72) 1.59 (1.01-2.52) 0.04 
Sensitivity analyses     
Frailty including weight loss     
 Participants, n 528 531 514  
 Frailty cases 14  23  58   
 Model 1a 1.00 1.89 (0.94-3.80) 5.26 (2.83-9.80) <0.001 
 Model 2b 1.00 1.66 (0.80-3.46) 4.25 (2.18-8.29) <0.001 
 Model 3c 1.00 1.64 (0.76-3.52) 4.09 (1.90-8.79) <0.001 
 Model 4d 1.00 1.41 (0.65-3.08) 2.95 (1.29-6.72) 0.005 
Defining weakness as lowest quintile of grip 
strength in our sample 
    
 Participants, n 528 531 514  
 Frailty cases 55 60 102  
 Model 1a 1.00 1.15 (0.77-1.72) 2.25 (1.55-3.26) <0.001 
 Model 2b 1.00 1.04 (0.67-1.59) 1.78 (1.19-1.66) 0.003 
 Model 3c 1.00 1.09 (0.69-1.72) 1.78 (1.10-2.88) 0.01 
 Model 4d 1.00 1.05 (0.66-1.68) 1.67 (1.01-2.80) 0.04 
Participants independent in IADL     
 Participants, n 478 474 448  
 Frailty cases 52 61 104  
 Model 1a 1.00 1.35 (0.90-2.02) 2.60 (1.79-3.77) <0.001 
 Model 2b 1.00 1.22 (0.80-1.88) 2.13 (1.43-3.19) <0.001 
 Model 3c 1.00 1.06 (0.68-1.65) 1.58 (0.99-2.52) 0.04 
 Model 4d 1.00 1.03 (0.65-1.62) 1.50 (0.91-2.49) 0.09 
Participants with optimal self-rated health     
 Participants, n 44 43 57  
 Frailty cases 413 372 320  
 Model 1a 1.00 1.20 (0.76-1.90) 1.86 (1.20-2.89) 0.006 
 Model 2b 1.00 1.15 (0.71-1.88) 1.66 (1.04-2.65) 0.03 
 Model 3c 1.00 1.03 (0.62-1.71) 1.32 (0.76-2.28) 0.32 
 Model 4d 1.00 1.03 (0.61-1.73) 1.33 (0.73-2.41) 0.35 
Participants without diagnosed chronic 
disease 
    
 Participants, n 284 229 203  
 Frailty cases 23 19 31  
 Model 1a 1.00 1.12 (0.58-2.15) 2.20 (1.22-3.98) 0.009 
 Model 2b 1.00 1.21 (0.61-2.40) 2.17 (1.15-4.12) 0.02 
 Model 3c 1.00 1.05 (0.52-2.12) 1.53 (0.73-3.21) 0.26 
 Model 4d 1.00 1.04(0.51-2.15) 1.51 (0.68-3.35) 0.32 
Participants who spent < 2 h/d watching TV     
 Participants, n 318 219 235  
 Frailty cases 35 31 49  
 Model 1a 1.00 1.43 (0.87-2.35) 2.23 (1.37-3.63) 0.001 
 Model 2b 1.00 1.30 (0.76-2.24) 1.96 (1.14-3.37) 0.01 
 Model 3c 1.00 1.11 (0.62-1.97) 1.45 (0.77-2.75) 0.24 
 Model 4d 1.00 1.05 (0.58-1.91) 1.33 (0.66-2.66) 0.40 
Participants whose diet had a Trichopoulou 
index ≥ 5 
    
 Participants, n 297 277 245  
 Frailty cases 36 44 63  
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 Model 1a 1.00 1.57 (0.96-2.58) 2.61 (1.63-4.20) <0.001 
 Model 2b 1.00 1.54 (0.90-2.65) 2.36 (1.40-3.98) 0.001 
 Model 3c 1.00 1.27 (0.72-2.26) 1.73 (0.93-3.19) 0.08 
 Model 4d 1.00 1.18 (0.65-2.12) 1.57 (0.81-3.05) 0.18 
 
IADL: Instrumental activities of daily living; TV: Television 
aModel 1: logistic regression model adjusted for sex and age (years). 
bModel 2: model 1 additionally adjusted for educational level (≤primary, secondary, university), smoking (never, former, current), leisure-time 
physical activity (quartiles of MET-h/wk), energy intake (quartiles of Kcal/d), alcohol consumption (never, former, moderate drinker, heavy 
drinker), Trichopoulou index score, hypertension, cardiovascular disease, cancer, chronic lung disease, osteomuscular disease, and depression. 
cModel 3: model 2 additionally adjusted for body fat (quartiles of %). 
dModel 4: model 3 additionally adjusted for HOMA-IR and CRP (mg/L).  
 
Over a median follow-up of 3.5 years, we identified 
280 (17.8%) persons with incident frailty. Using the five-
criterion definition of frailty (i.e. including weight loss), 
there was 95 (6.0%) incident cases. After adjustment for 
potential confounders except for body fat percentage 
(model 2), and compared to individuals in the lowest 
tertile of leptin concentration, the OR (95% CI) for frailty 
was 1.27 (0.87-1.87) in the second tertile, and 2.12 (2.12-
3.06) in the highest tertile (p-trend <0.001).  After 
additional adjustment for body fat percentage, the 
corresponding results were 1.19 (0.79-1.78) and 1.69 
(1.11-2.61; p-trend=0.01). Finally, with further 
adjustment for HOMA-IR and CRP the results were 1.14 
(0.75-1.72) and 1.59 (1.01-2.52; p-trend=0.04) (Table 2). 
Results were in the same direction when the weight loss 
criterion was included in the definition of frailty and when 
sample-specific cut-offs for grip strength were used, as 
well as among individuals with better health status, and in 
those with non-sedentary behavior or better adherence to 
the Mediterranean diet (Table 2). 
 
 
 
Table 3. Odds ratios (95% confidence interval) for the association between serum concentration of leptin and risk 
of frailty, by abdominal obesity and body fat (N=1,573). 
 
            Leptin concentration   
                 Tertile 1 
(lowest) 
Tertile 2 
Tertile 3 
(highest) 
p-trend p-interaction† 
Abdominal obesity      
 Participants, n 287 288 285   
 Frailty cases  46 62 90   
 Model 1a 1.00 1.15 (0.71-1.86) 1.94 (1.15-3.26) 0.006  
 Model 2b 1.00 1.09 (0.64-1.85) 1.56 (0.88-2.77) 0.09  
No abdominal obesity      
 Participants, n 238 238 237  
 Frailty cases 25 19 38   
 Model 1a 1.00 0.73 (0.38-1.43) 1.74 (0.85-3.56) 0.12 0.12 
 Model 2b 1.00 0.69 (0.33-1.41) 1.72 (0.79-3.72) 0.15 0.16 
Body fat % ≥ median in 
study sample  
     
 Participants, n 262 263 262   
 Frailty cases 42 58 86   
 Model 1a 1.00 1.17 (0.64-2.13) 1.88 (1.08-3.25) 0.001  
 Model 2b 1.00 1.12 (0.59-2.13) 1.69 (0.93-3.06) 0.02  
Body fat % < median in 
study sample  
     
 Participants, n 265 260 261  
 Frailty cases 25 29 36   
 Model 1a 1.00 1.37 (0.83-2.28) 2.14 (1.09-4.20) 0.02 0.47 
 Model 2b 1.00 1.38 (0.79-2.40) 2.03 (0.96-4.29) 0.05 0.56 
 
†Comparing the same model in the complementary stratum. 
Abdominal obesity: waist circumference >102 cm in men and >88 cm in women 
Median of body fat % in study sample: 30.6% in men and 42.1% in women. 
aModel 1: logistic regression model adjusted for sex and age (years). 
bModel 2: model 1 additionally adjusted for educational level (≤primary, secondary, university), smoking (never, former, current), leisure-time 
physical activity (quartiles of MET-h/wk), energy intake (quartiles of Kcal/d), alcohol consumption (never, former, moderate drinker, heavy 
drinker), Trichopoulou index score, hypertension, cardiovascular disease, cancer, chronic lung disease, osteomuscular disease, and depression. 
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Table 4. Odds ratios (95% confidence interval) for the association between plasma concentration of leptin 
and risk of each frailty criterion. (N=1,573) 
 
 Leptin concentration  
 
Tertile 1 
(lowest) 
Tertile 2 
Tertile 3 
(highest) 
p-trend 
Participants, n 528 531 514  
Exhaustion     
 Criterion present 49 55  96   
 Model 1a 1.00 1.16 (0.77-1.76) 2.29 (1.57-3.34) <0.001 
 Model 2b 1.00 1.06 (0.68-1.65) 2.05 (1.36-3.10) <0.001 
 Model 3c 1.00 1.12 (0.70-1.79) 2.16 (1.32-3.55) 0.001 
 Model 4d 1.00 1.14 (0.71-1.84) 2.24 (1.32-3.80) 0.002 
Low physical activity     
 Criterion present 67 71  105  
 Model 1a 1.00 1.06 (0.74-1.52) 1.77 (1.26-2.47) 0.001 
 Model 2b 1.00 0.97 (0.64-1.42) 1.40 (0.97-2.01) 0.06 
 Model 3c 1.00 0.94 (0.63-1.40) 1.18 (0.77-1.81) 0.42 
 Model 4d 1.00 0.91 (0.60-1.37) 1.11 (0.70-1.77) 0.61 
Slow walking speed     
 Criterion present 64 68  85   
 Model 1a 1.00 1.10 (0.76-1.15) 1.41 (0.99-2.01) 0.06 
 Model 2b 1.00 1.08 (0.74-1.57) 1.30 (0.90-1.89) 0.16 
 Model 3c 1.00 1.14 (0.77-1.69) 1.48 (0.96-2.29) 0.08 
 Model 4d 1.00 1.01 (0.67-1.52) 1.19 (0.74-1.92) 0.46 
Muscle weakness     
 Criterion present 132 149  230   
 Model 1a 1.00 1.26 (0.94-1.69) 2.61 (1.97-3.46) <0.001 
 Model 2b 1.00 1.17 (0.86-1.58) 2.35 (1.75-3.17) <0.001 
 Model 3c 1.00 1.05 (0.76-1.43) 1.77 (1.25-2.51) 0.001 
 Model 4d 1.00 1.01 (0.73-1.40) 1.68 (1.15-2.44) 0.005 
Weight loss     
 Criterion present 31 32 43  
 Model 1a 1.00 1.04 (0.62-1.73) 1.45 (0.90-2.35) 0.12 
 Model 2b 1.00 1.02 (0.61-1-73) 1.40 (0.84-2.33) 0.18 
 Model 3c 1.00 0.98 (0.57-1.69) 1.34 (0.74-2.42) 0.32 
 Model 4d 1.00 0.97 (0.55-1.67) 1.25 (0.66-2.35) 0.49 
 
aModel 1: logistic regression model adjusted for sex and age (years). 
bModel 2: model 1 additionally adjusted for educational level (≤primary, secondary, university), smoking (never, former, current), 
leisure-time physical activity (quartiles of MET-h/wk), energy intake (quartiles of Kcal/d), alcohol consumption (never, former, 
moderate drinker, heavy drinker), Trichopoulou index score, hypertension, cardiovascular disease, cancer, chronic lung disease, 
osteomuscular disease, and depression. 
cModel 3: model 2 additionally adjusted for body fat (quartiles of %). 
dModel 4: model 3 additionally adjusted for HOMA-IR and CRP (mg/L).  
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In stratified analyses, the association between leptin 
and risk of frailty was similar in those with or without 
abdominal obesity, and in those with body fat percentage 
above or below the sample median (Table 3). 
Table 4 presents the association between leptin 
concentrations and each frailty criterion.  Compared to 
individuals in the lowest tertile of leptin, those in the 
highest tertile showed a tendency to increased risk of all 
criteria, though statistical significance was only achieved 
for exhaustion (model 3, OR: 2.16; 95% CI: 1.32-3.55; p-
trend=0.001) and muscle weakness (model 3, OR: 1.77; 
95% CI: 1.25-2.51; p-trend=0.001).  
 
DISCUSSION  
 
In this study among community-dwelling older adults, 
higher leptin serum concentrations were associated with 
incident frailty. This association was observed regardless 
of abdominal obesity or body fat percentage, and was only 
modestly explained by insulin resistance or chronic 
inflammation, as represented by CRP levels. 
To our knowledge, this is the first longitudinal study 
to examine the risk of frailty associated with leptin 
concentrations. However, one investigation has found 
indirect evidence for this association, which is consistent 
with our results. Specifically, Aguirre et al. have recently 
reported that the association between high body fat mass 
and low bone density, which is a predictor of frailty, is 
mediated by leptin in older adults (24).  
In healthy individuals, leptin reduces food intake and 
increases energy expenditure, so it contributes to energy 
balance (9,10). However, there are at least two situations 
that could alter the physiology of leptin and could be 
related to some deleterious health effects. First, several 
diseases and severe disability can alter the effect of leptin 
on the hypothalamus, which is the main target of leptin 
(9). For instance, low leptin concentrations in patients 
with cancer are not associated with greater appetite, 
suggesting a disturbance in the hypothalamic response to 
leptin (25). Also, another study found low leptin levels in 
a small sample of institutionalized frail older adults, 
which was accompanied by increased levels of CRP and 
interleukin-6 (26). It is possible that, in these cases, low 
leptin levels simply reflect malnutrition status, which is 
also related to frailty. To rule out the role of baseline 
malnutrition in the study association, we excluded from 
the analyses one individual with BMI <18.5 kg/m2. 
Moreover, the association between leptin and frailty was 
observed even in those free of IADL limitations, with no 
diagnosed chronic diseases or with optimal reported 
health. 
Second, given that leptin levels reflect overall adipose 
mass (9,10), obese people have elevated leptin 
concentrations, which nevertheless are not able to control 
obesity by reducing food consumption; in fact, 
administration of leptin to obese individuals does not lead 
to weight loss (11). These findings have been interpreted 
as representing a state of leptin resistance (11). The 
ageing-associated loss of muscle mass is often 
accompanied by gains in fat mass, even in the absence of 
obvious signs of obesity (27). This increase in adipose 
tissue is mostly located in the abdomen and infiltrating the 
skeletal muscle. Therefore, the state of hyperleptinemia 
and leptin resistance that concurs in obese people may 
similarly affect older individuals, a fact which has already 
been demonstrated in animals (28). Also, given that both 
ageing and obesity are risk factors for frailty, an 
association between higher leptin and increased risk of 
frailty was to be expected. This is consistent with the 
association between leptin and muscle weakness observed 
in our study.  
Sarcopenia (reduced skeletal muscle mass and 
strength) plays a key role in the pathogenesis of frailty, 
leading to reduced physical activity, lower gait speed and 
greater fatigue (1,2,29). Among the potential mechanisms 
is the obesity-derived intracellular lipotoxicity (i.e., 
elevated intramuscular levels of lipids and their 
derivatives), which induces apoptosis by means of an 
elevated oxidative stress (30). Also in obesity, muscle 
progenitor cells could differentiate to an adipocyte-like 
phenotype as a result of paracrine signals from adipo-
cytokines leading to a reduced muscular renewal capacity 
(30). Interestingly, there is evidence that leptin 
concentrations are elevated in sarcopenic obesity (31), 
which in turn is an important risk factor for frailty 
(1,2,32). Lastly, in a recent study of 139,691 subjects from 
17 countries, reduced grip strength has been prospectively 
linked to higher risk of cardiovascular and all-cause death 
(33). Therefore, our results are of particular importance 
because they showed an association of leptin with both 
frailty and muscle weakness, each of them being a 
clinically relevant outcome. 
It is known that higher leptin may lead to higher 
production of proinflammatory cytokines, which are 
related to IR (9,10). In fact, in our cohort, being in a higher 
leptin tertile was associated with higher HOMA-IR and 
CRP. Thus, we hypothesized that the leptin-frailty 
association could be mediated, at least partially, by IR and 
inflammation. However, the adjusted OR of frailty for the 
highest versus lowest tertile of leptin was 1.69 and it was 
reduced to only 1.59 after additional adjustment for 
HOMA-IR and CRP. This suggests that the study 
association was only modestly explained by HOMA-IR 
and CRP. However, the role of other biomarkers of 
inflammation or oxidative stress, such as interleukin-6, 
tumor necrosis factor-alpha or reactive oxygen 
metabolites, cannot be entirely ruled out because they 
were not measured in this study.  
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Lastly, we found no evidence that abdominal obesity 
or body fat percentage modified the association between 
leptin and frailty. However, stratified analyses lead to 
smaller sample sizes and may limit the power to find 
statistical interactions. Moreover, body fat percentage was 
estimated with the CUN-BAE equation rather than 
directly measured. Therefore, our results should be 
confirmed in future studies with a larger sample size and 
direct measures of fat mass.  
Our study had several strengths and limitations. 
Among the first, is that most variables, including leptin 
and frailty, were measured with standardized and valid 
methods. Also the analyses adjusted for a good number of 
potential confounders, and the main results held after 
many sensitivity analyses. The main limitation was the 
lack of measurement of the soluble receptor of leptin, 
which has shown a stronger relation than leptin with some 
health outcomes (34). Neither did we measure other 
adipokines, particularly adiponectin; it seems that the 
joint assessment of leptin and adiponectin may be more 
biologically relevant than of leptin alone (10,35). 
However, we have attempted to partially account for this 
limitation by adjusting the analyses for body fat 
percentage, as a proxy for adipokines secretion. 
 
Conclusion 
 
In conclusion, in this prospective study of older adults, 
serum leptin concentrations were positively associated 
with incident frailty. Future research should confirm this 
finding. Future studies should also establish whether this 
association could be better characterized by the soluble 
receptor of leptin, and whether it is independent of the role 
of other adipokines. Moreover, the mechanisms of this 
association need to be elucidated.  
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